Compounded GLP-1 drugs are versions of GLP-1 medications created by compounding pharmacies rather than manufactured by pharmaceutical companies
[99] showed different results using a retrospective matched cohort study that utilized the TriNetX, found no increased risk of NAION or ischemic optic neuropathy among patients with T2DM or elevated BMI prescribed semaglutide over 5 years
$278/mo all-in, live video specialists
Microdosing is entirely off-label, as there is no set dosing for it
In a phase 1 clinical trial, maridebart cafraglutide effectively reduced body weight in participants with obesity (74)
GLP-1 medications work by interacting with specific receptors in the pancreas, digestive system, and brain, helping to increase feelings of fullness, slow gastric emptying, and reduce hunger cravings